Drug Profile
Paclitaxel-releasing balloon - MINVASYS
Alternative Names: Danubio® Paclitaxel Eluting Balloon; Drug eluting balloon - MINVASYS; Paclitaxel Drug Eluting Balloon - MINVASYSLatest Information Update: 15 Jan 2022
Price :
$50
*
At a glance
- Originator MINVASYS
- Class Antineoplastics; Diterpenes; Paclitaxels; Skin disorder therapies; Small molecules; Taxanes; Vascular disorder therapies
- Mechanism of Action Immunosuppressants; Mitosis inhibitors; Proto-oncogene protein c-bcl-2 inhibitors; Tubulin inhibitors; Tubulin polymerisation promoters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Coronary artery restenosis
Most Recent Events
- 01 Mar 2012 Phase-II clinical trials in Coronary artery restenosis in France (Intracoronary) (NCT01485068)
- 18 Jan 2012 Preclinical trials in Coronary artery restenosis in France (Intracoronary)